牛牛AI助手已提取核心信息
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on February 1, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a result, the total value of the shares after the action remains unknown.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on February 1, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a result, the total value of the shares after the action remains unknown.
百时美施贵宝（BMY）的举报人菲利斯·耶鲁于2024年2月1日参与了该公司股票的交易。公告中未披露交易的具体细节，例如行动类型、状态、股票数量、股票性质、交易价格和交易后持有量。因此，行动后股票的总价值仍然未知。
百时美施贵宝（BMY）的举报人菲利斯·耶鲁于2024年2月1日参与了该公司股票的交易。公告中未披露交易的具体细节，例如行动类型、状态、股票数量、股票性质、交易价格和交易后持有量。因此，行动后股票的总价值仍然未知。
有用
没用